![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Amoxapine (Ascendin®) is a new tricyclic antidepressant marketed by Lederle Laboratories. Chemically, amoxapine resembles the neuroleptic loxapine, while pharmacologically, amoxapine is similar to imipramine [1]. The following case report describes the clinical presentation and management of an acute amoxapine intoxication.